EUA
Novel Coronavirus (SARS-CoV-2) Fast Nucleic Acid Detection Kit (PCR-Fluorescence Probing)
FDA Emergency Use Authorization · Jiangsu CoWin Biotech Co., Ltd. · Jul 24, 2020
Key facts
| Product | Novel Coronavirus (SARS-CoV-2) Fast Nucleic Acid Detection Kit (PCR-Fluorescence Probing) |
|---|---|
| Company | Jiangsu CoWin Biotech Co., Ltd. |
| Product type | Real-time RT-PCR, Multiple Targets |
| Date | Jul 24, 2020 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: